Evaluation of the Efficacy and Safety of Recombinant Human Growth Hormone (rhGH) in the Treatment of Children With Short Bowel Syndrome

Clinical trial NCT00169637 · COMPLETED

Trial details

NCT number: NCT00169637
Sponsor: Hospices Civils de Lyon
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Short Bowel Syndrome

Start date: 2006-06-01
Primary completion: 2008-06-01
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.